Saranac Partners Ltd

Position in ABBV — AbbVie Inc.

CIK 2098745 LONDON, X0

Position in ABBV

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$10,338,881

+$2,822,210 QoQ

Shares Held

41,086

+18.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

3.48%

of 13F equity value

Holder Rank

#906

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Saranac Partners Ltd holds $13,142,776 across 6 Drug Manufacturers - General names. ABBV ranks #1 (78.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	41,086	$10,338,881
2	AZN	Astrazeneca PLC	4,522	$857,461
3	LLY	ELI LILLY & Co	487	$584,122
4	NVO	Novo Nordisk A S	11,090	$531,654
5	BMY	Bristol Myers Squibb Co	7,311	$421,259
6	JNJ	Johnson & Johnson	1,612	$409,399

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,338,881	41,086	+18.9%	Shares	Sole	2026-08-13
2026-03-31	$7,516,671	34,561	-11.9%	Shares	Sole	2026-05-15
2025-12-31	$8,966,633	39,243	+26.3%	Shares	Sole	2026-02-06
2025-09-30	$7,195,985	31,079	+9.9%	Shares	Sole	2025-12-05
2025-06-30	$5,250,261	28,285	-8.5%	Shares	Sole	2025-12-15
2025-03-31	$6,479,615	30,926	-3.2%	Shares	Sole	2025-12-15
2024-12-31	$5,675,204	31,937	+3.8%	Shares	Sole	2026-02-02
2024-09-30	$6,078,236	30,779	-7.9%	Shares	Sole	2026-02-02
2024-06-30	$5,729,625	33,405	+4.0%	Shares	Sole	2026-02-02
2024-03-31	$5,851,055	32,131	-9.1%	Shares	Sole	2026-02-02
2023-12-31	$5,474,935	35,329	-35.5%	Shares	Sole	2026-02-02
2023-09-30	$8,168,040	54,797	+0.6%	Shares	Sole	2026-02-02
2023-06-30	$7,337,665	54,462	+10.9%	Shares	Sole	2026-02-06
2023-03-31	$7,823,632	49,091	+211.8%	Shares	Sole	2026-02-06
2022-12-31	$2,544,064	15,742	—	Shares	Sole	2026-02-06
No filing history on record for this holder in this stock.